Christoph Röllig
Städtisches Klinikum Dresden(DE)University Hospital Carl Gustav Carus(DE)Klinik und Poliklinik für Psychotherapie und Psychosomatik(DE)Hochschule für Technik und Wirtschaft Dresden – University of Applied Sciences(DE)Technische Universität Dresden(DE)TU Dresden(DE)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Multiple Myeloma Research and Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN(2022)2,785 cited
- → Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma(2015)1,311 cited
- → Multiple myeloma(2014)598 cited
- → Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)(2020)545 cited
- → Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study(2017)486 cited
- → Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial(2015)